Market News (Page 3) - TendieTensor

Market News Page 3 of 232 • 5,797 articles

The Motley Fool • Joe Tenebruso

Why Dynavax Stock Soared Today

12/24/2025 03:35 PM • Dynavax Technologies stock surged 38.19% after French pharmaceutical giant Sanofi announced an all-cash tender offer to acquire the biotech company for $15.50 per share, valuing it at approximately $2.2 billion. The deal represents a 39% premium to Dynavax's previous closing price and combines Dynavax's hepatitis B and shingles vaccines with Sanofi's global distribution network and development expertise.

WFCpL - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
DVAX - Stock soared 38.19% following announcement of acquisition by Sanofi at a 39% premium to previous closing price, providing shareholders with significant value and certainty of exit.

#acquisition #tender offer #vaccine #hepatitis B #shingles #biotech #merger

Video Presentation Explores What Altucher Calls “The Convergence of the Century”

GlobeNewswire Inc. • James Altucher

Video Presentation Explores What Altucher Calls “The Convergence of the Century”

12/24/2025 02:44 PM • Technology analyst James Altucher released a video presentation arguing that the convergence of artificial intelligence and quantum computing represents a historic inflection point comparable to past technological breakthroughs. He cites Bank of America's projection of $111 trillion in potential new wealth and highlights growing momentum through increased patent filings, major tech firm investments, and real-world testing in healthcare, logistics, and finance sectors.

WFCpD - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
BAC - Bank of America is cited as a credible institutional source projecting $111 trillion in wealth creation from AI-quantum convergence, positioning the bank as a research authority on this technological shift and implicitly supporting the investment thesis.

#artificial intelligence #quantum computing #technological convergence #market inflection point #wealth creation #emerging technologies #patent filings #investment trends

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Coupang, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CPNG

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Coupang, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CPNG

12/24/2025 02:44 PM • Rosen Law Firm has filed a class action lawsuit against Coupang, Inc. on behalf of investors who purchased securities between August 6, 2025 and December 16, 2025. The lawsuit alleges that Coupang failed to disclose a significant data breach caused by inadequate cybersecurity protocols that allowed a former employee to access sensitive customer information for nearly six months. The firm claims defendants made false and misleading statements and failed to file required SEC reports regarding the breach, causing investor damages when the true details became public.

WFCpC - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
CPNG - The company is the subject of a securities class action lawsuit alleging inadequate cybersecurity protocols, unauthorized data access by a former employee, failure to properly disclose the breach to the SEC, and making false/misleading statements to investors. These allegations of fraud and regulatory non-compliance represent significant legal and reputational risks.

#class action lawsuit #data breach #cybersecurity #securities fraud #SEC disclosure #investor damages #lead plaintiff deadline

Mondelēz Global LLC Conducts Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US

GlobeNewswire Inc. • Na

Mondelēz Global LLC Conducts Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US

12/24/2025 02:00 PM • Mondelēz Global LLC issued a voluntary recall of CHIPS AHOY! Baked Bites Brookie products due to an incorrect mixing process that created corn starch clumps, posing a potential choking hazard for young children and elderly consumers. The recall is limited to specific Best When Used By dates and a limited number of retail stores. No injuries or illnesses have been reported.

GSpD - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
MDLZ - The voluntary recall of a consumer product indicates a manufacturing quality control issue. While the company is being proactive and no injuries have been reported, recalls can damage brand reputation and consumer trust, and may result in financial costs related to the recall process and potential legal liability.

#product recall #choking hazard #CHIPS AHOY! #corn starch clumps #food safety #manufacturing defect

GBPPromote Launches Google Reviews Management Software

GlobeNewswire Inc. • Gbppromote

GBPPromote Launches Google Reviews Management Software

12/24/2025 01:49 PM • GBPPromote has launched a new Google Reviews Management Software designed to help businesses manage online reviews, protect their reputation, and build customer trust. The platform features a unified dashboard, automated review requests, sentiment analysis, and bad review detection. With over 5,000 agencies already onboarded, GBPPromote is expanding its offerings with upcoming tools for Google Business Profile management, local citation tracking, and local rank monitoring.

WFC - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
GOOG - Google is mentioned primarily as the platform whose reviews GBPPromote manages. While the article references Google's review moderation efforts (170M+ reviews removed in 2023, 240M+ in 2024), this is presented as factual context rather than positive or negative commentary on Google's business performance.

#Google Reviews Management #online reputation #review automation #local SEO #Google Business Profile #customer trust #review generation #sentiment analysis #multi-location management #fake review detection

What's the Best-Performing S&P 500 Stock in 2025?

The Motley Fool • Matthew Benjamin

What's the Best-Performing S&P 500 Stock in 2025?

12/24/2025 01:32 PM • Sandisk (SNDK) is the best-performing S&P 500 stock in 2025, with shares up 570% since its February IPO at $38.50, now trading around $250. The memory and storage device manufacturer benefited from a global chip shortage driven by AI and consumer electronics demand, posting strong Q1 results with 21% revenue growth to $2.3B and earnings more than double analyst expectations.

WFCpA - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
SNDK - Exceptional 570% stock price gain in 2025, strong fiscal Q1 earnings beat (earnings 2x+ consensus, revenue 9% above expectations), benefits from global memory chip shortage driven by AI competition, and positive market reception with 15% pop after earnings announcement.

#Sandisk #S&P 500 #best-performing stock #NAND flash memory #chip shortage #AI demand #IPO #earnings beat

Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

Benzinga • Vandana Singh

Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

12/24/2025 12:31 PM • The FDA approved Novo Nordisk's Wegovy pill, the first oral GLP-1 weight-loss medication, which demonstrated 16.6% mean weight loss in trials. As GLP-1 adoption accelerates, major food and restaurant companies are rapidly adjusting their menus and products toward higher-protein, smaller-portion offerings to cater to changing consumer eating habits, with companies like ConAgra, Chipotle, and Danone already seeing strong performance in these new product lines.

GSpC - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
NVO - FDA approval of Wegovy pill as first oral GLP-1 therapy with strong clinical trial results (16.6% mean weight loss) and expected U.S. launch in early January 2026 represents significant market expansion opportunity.

#GLP-1 medications #Wegovy pill approval #weight loss drugs #menu innovation #high-protein products #portion control #consumer eating habits

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

12/24/2025 11:50 AM • Rezolute's stock plummeted on December 11, 2025, following disappointing results from its Phase 3 sunRIZE clinical trial for ersodetug, a lead drug candidate for congenital hyperinsulinism. The study failed to meet its primary and key secondary endpoints, with the highest dose showing statistically insignificant reductions in hypoglycemia events versus placebo. Securities law firm Faruqi & Faruqi is investigating potential claims against the company on behalf of affected investors.

RZLT - The company's lead drug candidate failed to meet primary and secondary endpoints in Phase 3 trials, resulting in sharp stock decline and triggering securities litigation investigation. This represents a significant setback for the company's pipeline and investor confidence.

#clinical trial failure #Phase 3 trial #stock decline #securities litigation #congenital hyperinsulinism #ersodetug #investor losses

Notice of Investigation of VRNS: Kessler Topaz Meltzer & Check, LLP Encourages Varonis Systems, Inc. (NASDAQ: VRNS) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

Notice of Investigation of VRNS: Kessler Topaz Meltzer & Check, LLP Encourages Varonis Systems, Inc. (NASDAQ: VRNS) Investors with Significant Losses to Contact the Firm

12/24/2025 11:50 AM • Law firm Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by Varonis Systems, Inc. after the company reported Q3 2025 results showing a 63.9% decline in term license subscription revenues and reduced full-year ARR guidance. The stock fell 48.67% on October 29, 2025, following disclosure of sales process issues and lower renewal rates in the on-premises subscription business.

VRNS - Company reported significant revenue miss with 63.9% decline in term license subscription revenues, reduced full-year ARR guidance, disclosed sales process issues, and experienced a 48.67% stock price decline. Federal securities law violations are being investigated by a major law firm.

#securities fraud investigation #Varonis Systems #revenue miss #subscription revenue decline #stock price drop #class action lawsuit #ARR guidance reduction

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sprouts

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sprouts

12/24/2025 11:39 AM • A securities class action has been filed against Sprouts Farmers Market for allegedly making false and misleading statements about the company's growth potential. On October 29, 2025, Sprouts reported disappointing third quarter results with comparable store sales declining 4.3% and reduced full-year guidance from 7.5%-9% to 7%. The stock fell $22.64 per share following the announcement. Investors who purchased securities between June 4 and October 29, 2025 have until January 26, 2026 to seek lead plaintiff status.

SFM - The company is facing a federal securities class action alleging false and misleading statements about growth potential. Q3 results showed a 4.3% decline in comparable store sales, significantly below projections, and full-year guidance was reduced. The stock price fell sharply ($22.64 per share) following the disappointing earnings announcement.

#securities litigation #class action #false statements #comparable store sales decline #guidance reduction #stock price decline #lead plaintiff deadline

NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

12/24/2025 11:36 AM • Nidec Corporation faces a securities investigation following multiple disclosures of improper accounting practices discovered by a third-party committee. The company revealed suspected inappropriate accounting involving management, customs value misreporting, and deficiencies in internal controls. These revelations triggered significant stock price declines across four separate announcements between September and October 2025, with the Tokyo Stock Exchange placing the company under a Special Security alert.

GS - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
NJDCY - Multiple accounting fraud allegations, management involvement in improper practices, audit disclaimer of opinion, withdrawal of financial forecasts, suspension of dividend payments, and Tokyo Stock Exchange Special Security alert designation. Stock declined approximately 68% from initial disclosure through final alert announcement.

#improper accounting #securities litigation #internal investigation #stock price decline #Tokyo Stock Exchange #internal controls #audit disclaimer

Why Is Dermata Therapeutics Stock Surging Wednesday?

Benzinga • Lekha Gupta

Why Is Dermata Therapeutics Stock Surging Wednesday?

12/24/2025 11:32 AM • Dermata Therapeutics (NASDAQ: DRMA) stock surged 20.10% on Wednesday following the announcement of a $12.4 million private placement offering. The company will issue 2,022,062 common shares and warrants priced at $2.04 per share, with expected gross proceeds of $4.1 million. If warrants are fully exercised, the company could raise an additional $8.3 million. Net proceeds will fund consumer research, OTC acne kit launch activities, and working capital. The stock is trading near its 52-week low of $1.96.

GSpA - Mentioned as a joint book-running manager for the offering, performing a standard financial service role
DRMA - Stock surged 20.10% on announcement of $12.4 million private placement offering with insider participation, providing capital for product launch and operations. However, the positive sentiment is tempered by the stock trading near its 52-week low, indicating underlying weakness despite the near-term rally.

#private placement offering #warrant exercise #capital raise #OTC acne kit #stock surge

HD Investors Have Opportunity to Join The Home Depot, Inc. Fraud Investigation with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

HD Investors Have Opportunity to Join The Home Depot, Inc. Fraud Investigation with the Schall Law Firm

12/24/2025 11:00 AM • The Schall Law Firm is investigating The Home Depot for potential securities violations following the company's Q3 2025 earnings announcement on November 18, 2025. Home Depot missed sales forecasts, attributing the shortfall to lack of storms and consumer uncertainty in housing. The stock fell over 6% on the news. The firm is seeking shareholders who suffered losses to participate in the investigation.

KMX - Only briefly mentioned with no substantive details about performance
HD - The company missed sales forecasts, experienced a 6% stock price decline, and is now subject to a fraud investigation by a securities litigation firm, indicating serious concerns about potential misstatements or disclosure failures to investors.

#fraud investigation #securities violation #earnings miss #shareholder lawsuit #Q3 2025 results

Lucid Takes On Tesla: $50K Crossover Is Coming For The Model Y

Benzinga • Erica Kollmann

Lucid Takes On Tesla: $50K Crossover Is Coming For The Model Y

12/24/2025 10:44 AM • Lucid Group is shifting from ultra-luxury to mass market with a new $50K midsize crossover (Project Midsize/Lucid Earth) scheduled for late 2026 production to compete with Tesla's Model Y. However, the company faces significant challenges as its Gravity SUV has experienced a sluggish rollout with minimal early sales, production issues, and a 60% stock decline in 2025. The affordable crossover represents a critical survival moment for the cash-burning automaker in an increasingly competitive EV landscape.

SNPS - Only briefly mentioned with no substantive details about performance
LCID - Despite the upcoming $50K crossover offering potential upside, Lucid faces severe near-term headwinds: Gravity SUV has failed to gain traction with minimal registrations, production guidance was trimmed, the stock dropped 60% in 2025, and the company is burning cash. The new crossover is positioned as a 'do-or-die' necessity for survival rather than a growth catalyst, indicating fundamental operational challenges.

#electric vehicles #EV market #mass market strategy #crossover vehicle #production challenges #supply chain #competitive pressure

uniQure Notice of Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

uniQure Notice of Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

12/24/2025 10:44 AM • Law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations by uniQure N.V. after the FDA rejected the company's Biologics License Application for AMT-130, a gene therapy for Huntington's disease. The rejection caused uniQure's stock to plummet over 50% on November 3, 2025, from $67.69 to $34.29. The firm is encouraging investors with significant losses to contact them.

QURE - FDA rejected the company's BLA submission for its lead drug candidate AMT-130, resulting in a 50%+ stock price decline and triggering a securities investigation for potential violations of federal securities laws.

#securities fraud investigation #FDA rejection #gene therapy #stock price decline #Biologics License Application #class action lawsuit

The Year Precious Metals Crushed Nvidia, Alphabet And Broadcom On The Charts

Benzinga • Piero Cingari

The Year Precious Metals Crushed Nvidia, Alphabet And Broadcom On The Charts

12/24/2025 10:33 AM • In 2025, precious metals significantly outperformed major tech stocks. Gold surged 70%, silver jumped 147%, and platinum climbed nearly 150%—all exceeding gains from Alphabet (66%), Broadcom (51%), and Nvidia (41%). The rally reflects a 'debasement trade' driven by concerns over government debt, inflation, and geopolitical risks, with nearly $93 billion flowing into precious metals ETFs globally.

NVDA - Nvidia's 41% year-to-date gain, while strong in absolute terms, significantly underperformed precious metals and was overshadowed by the broader market rotation away from tech stocks toward safe-haven assets.

#precious metals #gold #silver #platinum #tech stocks underperformance #debasement trade #ETF flows #fiscal deficits #monetary metals

3 Things to Watch With SIRI Stock in 2026

The Motley Fool • Rick Munarriz

3 Things to Watch With SIRI Stock in 2026

12/24/2025 10:32 AM • Sirius XM stock has declined 10% in 2025 and lost two-thirds of its value over five years, but trades at a cheap 6.6x forward earnings with a 5.2% dividend yield. Three key factors to watch in 2026: potential revenue growth reversal after three years of declines, the impact of Howard Stern's new three-year contract on cost-cutting efforts, and Berkshire Hathaway's next moves with its 37.1% stake in the company.

SIRI - The company faces structural headwinds with three years of revenue declines and a 10% stock drop in 2025, but shows some positive catalysts including potential marginal revenue growth in 2026, cost-cutting initiatives, and a cheap valuation. The Howard Stern contract renewal provides content stability but may limit further cost reductions.

#satellite radio #revenue decline #cost savings #Howard Stern #dividend yield #valuation #subscriber count #shareholder activism

3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade

The Motley Fool • Leo Sun

3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade

12/24/2025 10:31 AM • The article recommends three foundational AI stocks for long-term investment: Nvidia, TSMC, and ASML. Nvidia dominates GPU production for AI data centers with strong competitive moats. TSMC manufactures Nvidia's advanced chips and benefits from the expanding AI market. ASML holds a monopoly on EUV lithography systems essential for producing cutting-edge semiconductors. All three are positioned to benefit from the AI market's projected 30.6% CAGR growth through 2033.

NVDA - Positioned as the leading GPU producer for AI with strong competitive advantages through CUDA ecosystem, first-mover edge, and best-in-breed reputation. Expected revenue and EPS CAGR of 46% and 29% respectively through fiscal 2028. Reasonably valued at 25x forward earnings despite 23,000% gain over past decade.

#artificial intelligence #semiconductor stocks #GPU manufacturing #chip production #long-term investment #AI market growth #lithography systems

KLAR Investors Have Opportunity to Join Klarna Group plc Fraud Investigation with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

KLAR Investors Have Opportunity to Join Klarna Group plc Fraud Investigation with the Schall Law Firm

12/24/2025 09:50 AM • The Schall Law Firm is investigating Klarna Group plc for potential securities law violations following a Bloomberg report revealing the company posted record revenue but a net loss of $95 million with higher-than-expected loan loss provisions of $235 million. The stock fell 9.3% following the earnings announcement, prompting the law firm to invite shareholders to join the investigation.

KLAR - The company reported record revenue but posted a net loss of $95 million with loan loss provisions significantly exceeding analyst estimates ($235M vs $215.8M expected). The 9.3% stock decline and subsequent fraud investigation indicate investor concerns about undisclosed credit quality deterioration and potential misleading financial disclosures.

#securities fraud #loan loss provisions #earnings miss #shareholder litigation #credit losses #misleading statements

FRMI Investors Have Opportunity to Join Fermi Inc. Fraud Investigation with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

FRMI Investors Have Opportunity to Join Fermi Inc. Fraud Investigation with the Schall Law Firm

12/24/2025 09:40 AM • The Schall Law Firm announced an investigation into Fermi Inc. (NASDAQ: FRMI) for potential securities law violations following a Bloomberg report that a major tenant terminated a $150 million lease agreement for Fermi's proposed AI campus in West Texas. The termination caused Fermi's stock to plunge as much as 46%. The investigation focuses on whether the company issued false or misleading statements or failed to disclose material information to investors.

FRMI - The company experienced a significant 46% stock price decline following a major tenant's termination of a $150 million lease agreement. Additionally, the company is under investigation for potential securities law violations related to false or misleading statements and inadequate disclosure of material information to investors.

#securities litigation #shareholder rights #lease termination #AI campus #stock decline #disclosure violations

Qianhai, Shenzhen: Ein rasch aufstrebendes neues Zentrum einer Megastadt, ein entscheidender Testfall für die Zusammenarbeit zwischen Guangdong, Hongkong und Macao

GlobeNewswire Inc. • Na

Qianhai, Shenzhen: Ein rasch aufstrebendes neues Zentrum einer Megastadt, ein entscheidender Testfall für die Zusammenarbeit zwischen Guangdong, Hongkong und Macao

12/24/2025 09:38 AM • Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone has achieved significant development in two years since its master plan launch in December 2023, attracting over 10,500 Hong Kong-funded enterprises with total capital exceeding 840 billion Yuan. The zone has implemented policy innovations including tax alignment and cross-border data platforms, established 18 specialized industrial clusters, and attracted 522 financial institutions, positioning itself as a key driver for Greater Bay Area development and a window for China's reform and opening initiatives.

PMRTY - Company established a regional headquarters in Qianhai, indicating confidence in the zone's development and business environment

#Qianhai #Shenzhen #Hong Kong #Greater Bay Area #institutional innovation #modern services #financial sector #cross-border cooperation #industrial clusters

Qianhai, Shenzhen : un nouveau centre urbain en pleine expansion, un terrain d’essai crucial pour la coopération Guangdong-Hong Kong-Macao

GlobeNewswire Inc. • Na

Qianhai, Shenzhen : un nouveau centre urbain en pleine expansion, un terrain d’essai crucial pour la coopération Guangdong-Hong Kong-Macao

12/24/2025 09:38 AM • Qianhai, a 120.56 km² cooperation zone between Shenzhen and Hong Kong, has achieved significant development in two years since the December 2023 plan launch. The zone has attracted over 10,500 Hong Kong-funded enterprises with 840 billion yuan in capital, implemented innovative cross-border policies, and established 522 financial institutions. It has become a national leader in free-trade zone innovation with 47 institutional innovations promoted nationwide.

PMRTY - Mentioned as a renowned company that has established its regional headquarters in Qianhai, indicating confidence in the zone's development and business environment.

#Qianhai #Shenzhen-Hong Kong cooperation #Greater Bay Area #financial services #institutional innovation #cross-border integration #modern services

Picard Medical Announces Up to $50 Million Senior Secured Debt Financing

GlobeNewswire Inc. • Na

Picard Medical Announces Up to $50 Million Senior Secured Debt Financing

12/24/2025 09:36 AM • Picard Medical, Inc., parent company of SynCardia Systems, announced a definitive agreement for a private placement of up to $50 million in senior secured notes due 2028 with warrants. The company expects to issue an initial $15 million at closing with options for up to $35 million additional in tranches. Proceeds will be used for working capital and general corporate purposes.

PMI - The company successfully secured a significant financing agreement of up to $50 million, demonstrating investor confidence and providing capital for operations and growth. This is a positive development for a medical device company with an FDA-approved product and over 2,100 implants globally.

#financing #senior secured notes #private placement #total artificial heart #SynCardia #capital raise

Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2025; Declares Annual Cash Dividend of $0.32 Per Share

GlobeNewswire Inc. • Paul Brunkhorst, Ceo

Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2025; Declares Annual Cash Dividend of $0.32 Per Share

12/24/2025 09:00 AM • Crazy Woman Creek Bancorp reported its best performance in 89 years with fiscal year 2025 net income of $1.9 million, achieving an 11.82% ROE and 0.97% ROA. The company increased its annual cash dividend to $0.34 per share and redeemed $2.0 million in subordinated notes. The bank maintains strong asset quality with nonperforming assets at 0.36% and a well-capitalized Tier 1 Leverage Ratio of 10.03%.

CRZY - Company reported record earnings in its 89-year history, increased dividend payout, improved asset quality metrics (nonperforming assets decreased from 0.72% to 0.36%), strong capital ratios exceeding well-capitalized standards, and net interest margin significantly above Wyoming average. All key financial indicators show strong performance and positive trajectory.

#record earnings #dividend increase #net income #return on equity #asset quality #capital ratios #net interest margin #community bank

Webus International Limited Expands into the U.S. Outdoor Smart Equipment and Robotics Market

GlobeNewswire Inc. • Na

Webus International Limited Expands into the U.S. Outdoor Smart Equipment and Robotics Market

12/24/2025 09:00 AM • Webus International Limited (NASDAQ: WETO) announced expansion into the U.S. outdoor smart sports equipment and robotics market through its subsidiary Wetour Travel Tech LLC. The company plans to develop AI-enabled wearable devices, smart vision equipment, and robotic-assisted mobility systems for outdoor activities. The expansion leverages Webus's existing expertise in travel and mobility technology, combining U.S.-led product design with globally optimized manufacturing.

WETO - The company is strategically expanding into high-growth markets (outdoor recreation, wearables, robotics, and edge AI) with double-digit growth potential. The expansion leverages existing operational expertise and combines U.S. market-led design with cost-efficient global manufacturing, positioning the company for long-term commercialization and competitive advantage.

#outdoor smart sports equipment #robotics #AI-powered hardware #wearable technology #intelligent mobility solutions #market expansion #TravelTech